Top Page
Archer Materials
(OTC:AXE)
Archer Materials (AXE) vs. iShares MSCI Australia ETF (EWA)
Archer Materials Business Overview & Revenue Model
Archer Materials Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.06M | 2.06M | 2.14M | 1.50M | 973.00K | 467.66K |
| Gross Profit | 2.06M | 2.06M | 2.14M | -53.74K | 922.59K | 435.36K |
| EBITDA | -6.94M | -6.94M | -5.11M | -8.66M | -14.97M | -3.24M |
| Net Income | -6.97M | -6.97M | -4.80M | -9.05M | -14.12M | -7.84M |
Balance Sheet | ||||||
| Total Assets | 17.47M | 17.47M | 22.89M | 27.21M | 30.17M | 19.69M |
| Cash, Cash Equivalents and Short-Term Investments | 13.82M | 13.82M | 18.78M | 24.19M | 28.17M | 8.93M |
| Total Debt | 14.97K | 14.97K | 109.31K | 9.10K | 19.75K | 30.09K |
| Total Liabilities | 752.16K | 752.16K | 1.09M | 1.21M | 746.23K | 732.71K |
| Stockholders Equity | 16.72M | 16.72M | 21.80M | 26.00M | 29.42M | 18.96M |
Cash Flow | ||||||
| Free Cash Flow | -4.19M | -4.19M | -4.99M | -3.21M | -4.44M | -2.32M |
| Operating Cash Flow | -4.19M | -4.19M | -4.79M | -3.03M | -4.30M | -2.22M |
| Investing Cash Flow | 4.11M | 4.11M | 6.98M | 2.31M | -94.83K | -262.25K |
| Financing Cash Flow | -96.30K | -96.30K | -115.82K | 64.90K | 24.62M | 606.22K |
Archer Materials Technical Analysis
Archer Materials Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $67.72M | 4.96 | 13.76% | 5.41% | -18.05% | -51.45% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | AU$965.95M | -23.62 | -50.48% | ― | 333.23% | 10.83% | |
55 Neutral | AU$117.23M | ― | -35.59% | ― | ― | -45.74% | |
50 Neutral | AU$20.61M | ― | -112.59% | ― | ― | -67.74% | |
44 Neutral | AU$392.74M | ― | -149.70% | ― | 503.29% | 11.46% | |
33 Underperform | AU$101.73M | ― | ― | ― | 44.80% | 7.69% |
Archer Materials Corporate Events
Archer Materials has announced successful initial results from its collaboration with IMEC on the development of a silicon-based Biochip for blood potassium sensing. The silicon devices achieved a potassium sensing accuracy of ±0.3 mM, matching clinical standards and offering faster readout times compared to current technologies. This advancement de-risks the Biochip supply chain, reduces costs, and accelerates commercialization. Archer plans to further refine the technology and pursue regulatory approvals, aiming for clinical trials and productization focused on chronic kidney disease diagnostics.
The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.
Archer Materials has made significant progress in its core areas of focus during the first quarter of FY26. The company advanced its 12CQ project by enhancing the readout of quantum information, bringing it closer to qubit functionality. Additionally, improvements in potassium ion testing on its biochip platform have brought it closer to clinical readiness, with a partnership with IMEC further accelerating development. Archer also demonstrated the operation of TMR sensors at cryogenic temperatures, which could have applications in quantum computing and aerospace. The company maintains a strong cash position with $11.6 million and no debt, supporting its R&D and commercial activities.
The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.
Archer Materials Limited announced that its CEO, Dr. Simon Ruffell, will present at the Semiconductor Australia 2025 conference. This presentation highlights Archer’s ongoing efforts to position itself as a leader in semiconductor innovation, potentially impacting its market presence and stakeholder interests.
The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.
Archer Materials Limited has announced its Annual General Meeting (AGM) for 2025, scheduled to take place on November 20th at the Stone & Chalk Sydney Scaleup Hub. The company encourages shareholders to participate either in person or by proxy, emphasizing the importance of shareholder engagement in the decision-making process. This meeting is a significant event for Archer Materials as it provides an opportunity for stakeholders to discuss the company’s strategic direction and operational updates.
The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.
Archer Materials has entered into a collaboration with Emergence Quantum to accelerate the development of quantum technology. This partnership focuses on utilizing graphene and carbon-based materials to advance next-generation quantum and electronic devices. The collaboration is structured around a phased Innovation and Commercialisation Program, which aims to translate scientific discoveries into practical technologies, thereby strengthening Archer’s position as a leader in quantum materials and device technology. Emergence Quantum’s expertise in strategic quantum technology development will support Archer in creating commercially viable products, enhancing its industry positioning and potential impact on stakeholders.
The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.
Archer Materials has achieved significant progress in its carbon-based qubit technology, building on its earlier EDMR breakthrough. The company has successfully demonstrated reproducible device performance and wafer-scale synthesis of its proprietary carbon material, which is compatible with CMOS technology. These advancements position Archer at the forefront of quantum computing innovation, with plans for a targeted qubit demonstration in mid-2026. The developments enhance Archer’s ability to produce scalable quantum devices that operate at room temperature, potentially impacting the quantum computing and sensing industries.
The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.
Archer Materials Limited has announced that its 2025 Annual General Meeting (AGM) will be held on November 20, 2025. A key agenda item will be the re-election of directors, with the deadline for director nominations set for October 2, 2025. This meeting is significant for stakeholders as it involves leadership decisions that could impact the company’s strategic direction and industry positioning.
The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.
Archer Materials Limited has released an updated investor presentation, highlighting its ongoing efforts in the semiconductor industry. This development underscores Archer’s commitment to advancing semiconductor technologies, which could significantly impact its market position and offer potential benefits to stakeholders through its innovative quantum computing and medical diagnostic chips.
The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.
Archer Materials Limited has announced the issuance of 1,474,962 performance rights as part of an employee incentive scheme, which are not intended to be quoted on the ASX. This move is likely aimed at motivating and retaining key personnel, potentially impacting the company’s operational efficiency and positioning within the advanced materials industry.
The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.
Archer Materials is progressing in the development of its Biochip technology with significant improvements in biosensor testing accuracy, aligning with clinical standards. The company is working on both graphene-based and silicon-based biosensor platforms, with the latter expected to facilitate quicker and more cost-effective commercialization, enhancing Archer’s market strategy and IP portfolio.
The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.
Archer Materials Limited has released its 2025 Corporate Governance Statement and Appendix 4G, highlighting its commitment to high standards of corporate governance. The statement outlines the company’s governance framework, policies, and practices designed to manage risks and ensure compliance, which are crucial for stakeholder confidence and trust. The Board’s oversight and integration of governance considerations into strategic decisions underscore Archer’s dedication to ethical and sustainable business practices.
The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.
Archer Materials has made significant progress in its 12CQ quantum project by demonstrating the Coulomb blockade phenomenon and improving spin coherence times, moving closer to achieving a functional qubit. The company is also advancing its Biochip platform with successful CMOS integration and biosensor enhancements, targeting applications in chronic kidney disease. These developments, along with strategic leadership changes and a strong financial position, underscore Archer’s commitment to innovation and commercialisation.
The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.